« Back to Search« Back to SearchSearch » Fetal Bovine Serum  Department of Health and Human Services, Centers for Disease Control and Prevention

Fetal Bovine Serum

  Atlanta, GA United States — Department of Health and Human Services, Centers for Disease Control and Prevention
Published February 10, 2016 — Deadline February 12, 2016 (3 years ago)
|
Notice type
Prior notice
THIS NOTICE IS FOR INFORMATIONAL PURPOSES ONLY.The Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases contemplates award of a firm-fixed-price sole source purchase order to VWR, 100 Matsonford Road, Radnor, PA 19087 for the purchase of premium grade, gamma irradiated Fetal Bovine Serum. No other products were considered because extnesive correlation studies of many weeks would have to be performed to validate the use of a different serum product with all of our cell lines at significant cost. Using identical laboratory products including media, reagents, and plasticware are essential to preventing variability and inconsistencies in results. It is essential to use validated products to maintain the continuity of research products, reagent development, and consistency in laboratory results. The North American Industrial Classification Standards (NAICS) Code is 325414 with a small business size standard of 500 employees. This acquisition will use sole source simplified procedures in accordance with FAR 13.106(b)(1). This requirement is not set aside for small businesses. CDC is not requesting competitive proposals and no solicitation is available. Interested parties who believe they possess the capabilities to satisfy this requirement should indicate their interest in writing and submit a capability statement demonstrating their ability to meet this requirement no later than 12:00 PM Eastern Standard Time, on February 12, 2016. Determination not to compete this proposed action based on responses to this notice is solely within the discretion of the Government. Respondents will assume all financial costs for preparing a response to this notice. The U.S. Government assumes no financial obligation for the preparation and distribution of prepared responses. Inquiries may be sent to Patrick Winders via email at vxx6@cdc.gov  

Full tender details available only for Oppex usersSign in

Fact Sheet

DATE
0210
YEAR
16
AGENCY
Department of Health and Human Services
OFFICE
Centers for Disease Control and Prevention
LOCATION
Procurement and Grants Office (Atlanta)
ZIP
30341-4146
CLASSCOD
65
NAICS
325414
OFFADD
2920 Brandywine Road, Room 3000 Atlanta GA 30341-4146
SUBJECT
Fetal Bovine Serum
SOLNBR
00hcvljb-2016-93917
RESPDATE
021216
CONTACT
Patrick J Winders, Phone 7704882669, Email vxx6@cdc.gov
DESC
THIS NOTICE IS FOR INFORMATIONAL PURPOSES ONLY.The Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases contemplates award of a firm-fixed-price sole source purchase order to VWR, 100 Matsonford Road, Radnor, PA 19087 for the purchase of premium grade, gamma irradiated Fetal Bovine Serum. No other products were considered because extnesive correlation studies of many weeks would have to be performed to validate the use of a different serum product with all of our cell lines at significant cost. Using identical laboratory products including media, reagents, and plasticware are essential to preventing variability and inconsistencies in results. It is essential to use validated products to maintain the continuity of research products, reagent development, and consistency in laboratory results. The North American Industrial Classification Standards (NAICS) Code is 325414 with a small business size standard of 500 employees. This acquisition will use sole source simplified procedures in accordance with FAR 13.106(b)(1). This requirement is not set aside for small businesses. CDC is not requesting competitive proposals and no solicitation is available. Interested parties who believe they possess the capabilities to satisfy this requirement should indicate their interest in writing and submit a capability statement demonstrating their ability to meet this requirement no later than 12:00 PM Eastern Standard Time, on February 12, 2016. Determination not to compete this proposed action based on responses to this notice is solely within the discretion of the Government. Respondents will assume all financial costs for preparing a response to this notice. The U.S. Government assumes no financial obligation for the preparation and distribution of prepared responses. Inquiries may be sent to Patrick Winders via email at vxx6@cdc.gov
URL
https://www.fbo.gov/spg/HHS/CDCP/PGOA/00hcvljb-2016-93917/listing.html
SETASIDE
N/A

Oppex helps organizations with a professional approach to public sector sales, to either grow their business locally or find new opportunities abroad. We are the largest source of public procurement data in Europe. We process and translate public tenders from over 1.000 local, national and international procurement portals and have acquired over 8 million tenders in our database.


Trusted By

KONE
NHS
3M
ABB